{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:47:22Z","timestamp":1761630442931},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,2,26]],"date-time":"2007-02-26T00:00:00Z","timestamp":1172448000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Dermatol"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Newer biological therapies for moderate-to-severe psoriasis are being used more frequently, but unexpected effects may occur.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentations<\/jats:title>\n            <jats:p>We present a group of 15 patients who developed inflammatory papules while on efalizumab therapy (Raptiva, Genentech Inc, anti-CD11a). Immunohistochemistry showed that there were increased CD11b<jats:sup>+<\/jats:sup>, CD11c<jats:sup>+<\/jats:sup> and iNOS<jats:sup>+<\/jats:sup> cells (myeloid leukocytes) in the papules, with relatively few CD3<jats:sup>+<\/jats:sup> T cells. While efalizumab caused a decreased expression of CD11a on T cells, other circulating leukocytes from patients receiving this therapy often showed increased CD11b and CD11c. In the setting of an additional stimulus such as skin trauma, this may predispose to increased trafficking into the skin using these alternative \u03b22 integrins. In addition, there may be impaired immune synapse formation, limiting the development of these lesions to small papules. There is little evidence for these papular lesions being \"allergic\" in nature as there are few eosinophils on biopsy, and they respond to minimal or no therapy even if efalizumab is continued.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We hypothesize that these papules may represent a unique type of \"mechanistic\" inflammatory reaction, seen only in the context of drug-induced CD11a blockade, and not during the natural disease process.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-5945-7-2","type":"journal-article","created":{"date-parts":[[2007,2,27]],"date-time":"2007-02-27T13:12:04Z","timestamp":1172581924000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series"],"prefix":"10.1186","volume":"7","author":[{"given":"Michelle A","family":"Lowes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Chamian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria V","family":"Abello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Papp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,2,26]]},"reference":[{"key":"72_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s10227-002-0118-1","volume":"7","author":"AB Gottlieb","year":"2003","unstructured":"Gottlieb AB, Miller B, Lowe N, Shapiro W, Hudson C, Bright R, Ling M, Magee A, McCall CO, Rist T, Dummer W, Walicke P, Bauer RJ, White M, Garovoy M: Subcutaneously administered efalizumab (anti-CD11a) improves signs and symptoms of moderate to severe plaque psoriasis. J Cutan Med Surg 2003, 7: 198\u2013207.","journal-title":"J Cutan Med Surg"},{"key":"72_CR2","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1056\/NEJMoa030002","volume":"349","author":"M Lebwohl","year":"2003","unstructured":"Lebwohl M, Tyring SK, Hamilton TK, Toth D, Glazer S, Tawfik NH, Walicke P, Dummer W, Wang X, Garovoy MR, Pariser D: A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N Engl J Med 2003, 349: 2004\u20132013. 10.1056\/NEJMoa030002","journal-title":"N Engl J Med"},{"key":"72_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1365-2133.2006.07344.x","volume":"155","author":"L Dubertret","year":"2006","unstructured":"Dubertret L, Sterry W, Bos JD, Chimenti S, Shumack S, Larsen CG, Shear NH, Papp KA: CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial. Br J Dermatol 2006, 155: 170\u2013181. 10.1111\/j.1365-2133.2006.07344.x","journal-title":"Br J Dermatol"},{"key":"72_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clim.2004.06.001","volume":"113","author":"Y Vugmeyster","year":"2004","unstructured":"Vugmeyster Y, Kikuchi T, Lowes MA, Chamian F, Kagen M, Gilleaudeau P, Lee E, Howell K, Bodary S, Dummer W, Krueger JG: Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin. Clin Immunol 2004, 113: 38\u201346. 10.1016\/j.clim.2004.06.001","journal-title":"Clin Immunol"},{"key":"72_CR5","doi-asserted-by":"publisher","first-page":"19057","DOI":"10.1073\/pnas.0509736102","volume":"102","author":"MA Lowes","year":"2005","unstructured":"Lowes MA, Chamian F, Abello MV, Fuentes-Duculan J, Lin SL, Nussbaum R, Novitskaya I, Carbonaro H, Cardinale I, Kikuchi T, Gilleaudeau P, Sullivan-Whalen M, Wittkowski KM, Papp K, Garovoy M, Dummer W, Steinman RM, Krueger JG: Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci U S A 2005, 102: 19057\u201319062. 10.1073\/pnas.0509736102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"72_CR6","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.1016\/j.jaad.2005.10.029","volume":"54","author":"W Carey","year":"2006","unstructured":"Carey W, Glazer S, Gottlieb AB, Lebwohl M, Leonardi C, Menter A, Papp K, Rundle AC, Toth D: Relapse, rebound, and psoriasis adverse events: an advisory group report. J Am Acad Dermatol 2006, 54: S171\u201381. 10.1016\/j.jaad.2005.10.029","journal-title":"J Am Acad Dermatol"},{"key":"72_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-5945-5-9","volume":"5","author":"MA Lowes","year":"2005","unstructured":"Lowes MA, Turton JA, Krueger JG, Barnetson RS: Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series. BMC Dermatol 2005, 5: 9. 10.1186\/1471-5945-5-9","journal-title":"BMC Dermatol"},{"key":"72_CR8","volume-title":"Immunology. The immune sysem in health and disease","author":"CA Janeway","year":"2001","unstructured":"Janeway CA, Travers P, Walport M, Shlomchik M: Immunology. The immune sysem in health and disease. 5th edition. New York, Garland Publishing; 2001.","edition":"5th"},{"key":"72_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0092-8674(01)00456-1","volume":"106","author":"YJ Liu","year":"2001","unstructured":"Liu YJ: Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001, 106: 259\u2013262. 10.1016\/S0092-8674(01)00456-1","journal-title":"Cell"},{"key":"72_CR10","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1182\/blood-2001-11-0097","volume":"100","author":"KP MacDonald","year":"2002","unstructured":"MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN: Characterization of human blood dendritic cell subsets. Blood 2002, 100: 4512\u20134520. 10.1182\/blood-2001-11-0097","journal-title":"Blood"},{"key":"72_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/labinvest.3780446","volume":"82","author":"WA Muller","year":"2002","unstructured":"Muller WA: Leukocyte-endothelial cell interactions in the inflammatory response. Lab Invest 2002, 82: 521\u2013533. 10.1038\/labinvest.3780446","journal-title":"Lab Invest"},{"key":"72_CR12","doi-asserted-by":"publisher","first-page":"7637","DOI":"10.1128\/IAI.73.11.7637-7643.2005","volume":"73","author":"M Guerau-de-Arellano","year":"2005","unstructured":"Guerau-de-Arellano M, Alroy J, Bullard D, Huber BT: Aggravated Lyme carditis in CD11a-\/- and CD11c-\/- mice. Infect Immun 2005, 73: 7637\u20137643. 10.1128\/IAI.73.11.7637-7643.2005","journal-title":"Infect Immun"},{"key":"72_CR13","volume-title":"Pulm Pharmacol Ther","author":"GC Nicholson","year":"2006","unstructured":"Nicholson GC, Tennant RC, Carpenter DC, Sarau HM, Kon OM, Barnes PJ, Salmon M, Vessey RS, Tal-Singer R, Hansel TT: A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: Upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist. Pulm Pharmacol Ther 2006."},{"key":"72_CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/089686080402400204","volume":"24","author":"T Liberek","year":"2004","unstructured":"Liberek T, Chmielewski M, Lichodziejewska-Niemierko M, Lewandowski K, Rutkowski B: Transmigration of blood leukocytes into the peritoneal cavity is related to the upregulation of ICAM-1 (CD54) and Mac-1 (CD11b\/CD18) adhesion molecules. Perit Dial Int 2004, 24: 139\u2013146.","journal-title":"Perit Dial Int"},{"key":"72_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2257.2004.00599.x","volume":"26","author":"V Latger-Cannard","year":"2004","unstructured":"Latger-Cannard V, Besson I, Doco-Lecompte T, Lecompte T: A standardized procedure for quantitation of CD11b on polymorphonuclear neutrophil by flow cytometry: potential application in infectious diseases. Clin Lab Haematol 2004, 26: 177\u2013186. 10.1111\/j.1365-2257.2004.00599.x","journal-title":"Clin Lab Haematol"},{"key":"72_CR16","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1172\/JCI23874","volume":"115","author":"K Maruyama","year":"2005","unstructured":"Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, Tomita M, Van Rooijen N, Takenaka H, D'Amore PA, Stein-Streilein J, Losordo DW, Streilein JW: Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 2005, 115: 2363\u20132372. 10.1172\/JCI23874","journal-title":"J Clin Invest"},{"key":"72_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1086\/498874","volume":"193","author":"AC Kirby","year":"2006","unstructured":"Kirby AC, Raynes JG, Kaye PM: CD11b regulates recruitment of alveolar macrophages but not pulmonary dendritic cells after pneumococcal challenge. J Infect Dis 2006, 193: 205\u2013213. 10.1086\/498874","journal-title":"J Infect Dis"},{"key":"72_CR18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nri1647","volume":"5","author":"P Friedl","year":"2005","unstructured":"Friedl P, den Boer AT, Gunzer M: Tuning immune responses: diversity and adaptation of the immunological synapse. Nat Rev Immunol 2005, 5: 532\u2013545. 10.1038\/nri1647","journal-title":"Nat Rev Immunol"},{"key":"72_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.it.2004.03.006","volume":"25","author":"W Lew","year":"2004","unstructured":"Lew W, Bowcock AM, Krueger JG: Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and \"Type 1\" inflammatory gene expression. Trends Immunol 2004, 25: 295\u2013305. 10.1016\/j.it.2004.03.006","journal-title":"Trends Immunol"},{"key":"72_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1517\/14712598.3.2.361","volume":"3","author":"JC Cather","year":"2003","unstructured":"Cather JC, Menter A: Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab. Expert Opin Biol Ther 2003, 3: 361\u2013370. 10.1517\/14712598.3.2.361","journal-title":"Expert Opin Biol Ther"}],"container-title":["BMC Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-5945-7-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-5945-7-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-5945-7-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-5945-7-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T08:52:45Z","timestamp":1630486365000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcdermatol.biomedcentral.com\/articles\/10.1186\/1471-5945-7-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,26]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["72"],"URL":"https:\/\/doi.org\/10.1186\/1471-5945-7-2","relation":{},"ISSN":["1471-5945"],"issn-type":[{"value":"1471-5945","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,26]]},"assertion":[{"value":"7 November 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}